These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6796855)

  • 21. [Pharmacological effects of captopril].
    Rubin B; Antonaccio J
    Nouv Presse Med; 1981 Apr; 10(19):1531-46. PubMed ID: 6269555
    [No Abstract]   [Full Text] [Related]  

  • 22. Captopril in hypertension after renal transplantation.
    Herlitz H; Ahlmén J; Aurell M; Blohmé I; Brynger H; Delin K; Larsson O
    Scand J Urol Nephrol Suppl; 1984; 79():111-4. PubMed ID: 6382584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of "therapy-resistant" forms of hypertension with captopril].
    Röckel A; Heidland A
    Med Klin; 1981 Jul; 76(15):427-33. PubMed ID: 7019656
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
    Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
    Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of captopril in arterial hypertension with a stable and malignant course].
    Lordkipanidze NL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Captopril in treatment-resistant hypertension (author's transl)].
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1987-91. PubMed ID: 7025191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Captopril].
    Belovezhov N
    Vutr Boles; 1981; 20(6):30-4. PubMed ID: 7039126
    [No Abstract]   [Full Text] [Related]  

  • 30. [Angiotensin converting enzyme--captopril].
    Kaneko Y; Shionoiri H; Uneda S; Fujishima S
    Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
    [No Abstract]   [Full Text] [Related]  

  • 31. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H
    Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term treatment of severe cardiac failure with captopril (author's transl)].
    Komajda M; Eugène M; Evans J; Lecossier D; Grosgogeat Y
    Nouv Presse Med; 1981 Apr; 10(19):1587-90. PubMed ID: 7025850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin, renin substrate, angiotensin II, and vasopressin in plasma during treatment with captopril in hypertension and heart failure.
    Fyhrquist F; Forslund T; Immonen I; Tikkanen I; Grönhagen-Riska C; Hortling L
    Acta Med Scand Suppl; 1983; 677():110-4. PubMed ID: 6367370
    [No Abstract]   [Full Text] [Related]  

  • 35. [A case of bilateral renovascular hypertension controlled by angiotensin converting enzyme inhibitor (captopril) after arterioplasty for predominantly stenotic side (author's transl)].
    Sakoda H; Ohashi H; Yoshida H; Morimoto K; Kawai C; Hara A; Matsunaga M; Kawamura J; Kumada K
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):167-73. PubMed ID: 7047823
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
    Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
    Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effectiveness of captopril in severe hypertension (author's transl)].
    Elkik F; Monteiro A; Corvol P; Milliez P
    Nouv Presse Med; 1981 Apr; 10(19):1557-63. PubMed ID: 7025845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors.
    Zusman RM
    Kidney Int; 1984 Jun; 25(6):969-83. PubMed ID: 6088887
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current aspects of the clinical effectiveness and tolerance of captopril in the treatment of cardiovascular diseases].
    Ol'binskaia LI; Mokhova OV
    Ter Arkh; 1984; 56(11):139-42. PubMed ID: 6395426
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients.
    McGrath BP; Matthews PG; Johnston CI
    Clin Exp Pharmacol Physiol; 1980; 7(5):487-91. PubMed ID: 7004680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.